Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development

 Preclinical exploration settlement delivers collectively Xilis' MicroOrganoSphere™ platform with MD Anderson's know-how in most cancers research and therapeutic progress
 
 HOUSTON...